Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Ford

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
JCO Precision Oncology|February 17, 2022
Precision Oncology: A New Forum for an Emerging FieldJames M Ford
JCO Precision Oncology|February 17, 2022
Totally Unexpected: Nonsyndromic <i>CDH1</i> Mutations and Hereditary Diffuse Gastric Cancer SyndromeJames M Ford
Science Translational Medicine|October 27, 2012
Lupus antibody tops cancer cellsJames M Ford
JAMA Oncology|July 17, 2015
Hereditary Gastric Cancer: An Update at 15 YearsJames M Ford
JCO Precision Oncology|February 9, 2022
Introducing the <i>JCO Precision Oncology</i> Molecular Tumor Board Case Discussion SeriesJames M Ford
Mutation Research|June 2, 2005
Regulation of DNA damage recognition and nucleotide excision repair: another role for p53James M Ford
Breast Cancer Research : BCR|August 24, 2012
Is breast cancer a part of Lynch syndrome?James M Ford
Molecular & Cellular Oncology|June 17, 2016
BRCA1: a movement toward cancer preventionElizabeth Alli, James M Ford
JAMA|October 18, 2012
Lynch syndrome in patients with colorectal cancer: finding the needle in the haystackUri Ladabaum, James M Ford
The Journal of Clinical Investigation|July 1, 2025
A triple-punch approach: methionine restriction enhances combination inhibitors in brain metastatic triple-negative breast cancerSamyuktha Suresh, James M Ford
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
JCO Precision Oncology|February 17, 2022
Precision Oncology: A New Forum for an Emerging FieldJames M Ford
JCO Precision Oncology|February 17, 2022
Totally Unexpected: Nonsyndromic <i>CDH1</i> Mutations and Hereditary Diffuse Gastric Cancer SyndromeJames M Ford
Science Translational Medicine|October 27, 2012
Lupus antibody tops cancer cellsJames M Ford
JAMA Oncology|July 17, 2015
Hereditary Gastric Cancer: An Update at 15 YearsJames M Ford
JCO Precision Oncology|February 9, 2022
Introducing the <i>JCO Precision Oncology</i> Molecular Tumor Board Case Discussion SeriesJames M Ford
Mutation Research|June 2, 2005
Regulation of DNA damage recognition and nucleotide excision repair: another role for p53James M Ford
Breast Cancer Research : BCR|August 24, 2012
Is breast cancer a part of Lynch syndrome?James M Ford
Molecular & Cellular Oncology|June 17, 2016
BRCA1: a movement toward cancer preventionElizabeth Alli, James M Ford
JAMA|October 18, 2012
Lynch syndrome in patients with colorectal cancer: finding the needle in the haystackUri Ladabaum, James M Ford
The Journal of Clinical Investigation|July 1, 2025
A triple-punch approach: methionine restriction enhances combination inhibitors in brain metastatic triple-negative breast cancerSamyuktha Suresh, James M Ford
Pageof 21